On the web
40th European Association for the Study of the Liver (EASL)
13-17 April 2005, Paris, France
An excellent selection of over 20 reports from this important European meeting are available on the NATAP website, including:
- Incidence and predictors of emergence of resistance to adefovir after 4 years follow-up
- Age & ribavirin dose reductions reduce SVR to peginterferon+ribavirin
- Cost effectiveness of peginterferon in HCV/HIV coinfection
- Albuferon: new HCV drug
- New HCV drug NM283: 24 week data at EASL
- New HCV drugs in development: EASL Report
Links to external websites are current at time of posting but not maintained.